/ Dr. Kingsley Chin
Kingsley R Chin MD, MBA
Founder, Chairman & CEO
KIC Ventures
Transforming Spine Surgery with Visionary Leadership
Meet
DR. KINGSLEY R CHIN MD MBA CEO
Dr. Kingsley R. Chin is the Founder, Chairman, and CEO of KIC Ventures, a private equity healthtech investment firm, where he directs the firm’s investment strategy, governance, and overall strategic direction. Dr. Chin oversees KIC Ventures' diverse portfolio of majority-owned spine companies, driving innovation and commercialization in spine surgery technologies. He also leads the firm’s executive management committees, ensuring alignment with its long-term vision and operational excellence.
Since the inception of KIC LLC, Dr. Chin has overseen more than 10 strategic transactions, beginning with the sale of MANTIS LLC to Stryker and including notable acquisitions such as the AxioMed viscoelastic disc replacement platform. These efforts have contributed to remarkable growth in equity value, achieving an increase of over 3,000x. With estimated assets under management (AUM) of $1 to $3 billion, KIC Ventures has established itself as a global leader in spine technology innovation under Dr. Chin’s leadership.
His unique blend of academic, clinical, and business expertise—with degrees from Columbia University, Harvard Medical School, and Harvard Business School, a tenure as Chief of Spine Surgery at the University of Pennsylvania, and experience as a former experienced management consultant at Accenture in New York City—guides his strategic oversight.
"In our journey to achieve success, let’s also invest in helping others succeed"
-Kingsley R Chin MD MBA
Revolutionizing Spine Surgery Technologies
Driven by an unwavering entrepreneurial spirit and early business experience in New York City, Dr. Chin’s journey into health technology innovations began during his formative years as an orthopedic resident at Harvard Medical School. Inspired by his professors' groundbreaking approaches to orthopedic technologies, Dr. Chin secured his first patent in 2000, setting the stage for a career marked by transformative advancements.
Harvard Orthopedic Residency: Dr. James H Herndon (left), Dr. Kingsley R Chin (middle) and Dr. Thomas S Thornhill (right)
In 2004, Dr. Chin introduced the MANTIS percutaneous pedicle screw system—a landmark innovation that became a cornerstone in the evolution of spine surgery technologies. This achievement was more than just a technical success; it represented a paradigm shift from traditional open spine surgeries to percutaneous, less invasive procedures, opening new possibilities for patient care.
Dr. Kingsley R Chin MD MBA
With over 30 years of experience, Dr. Chin remains steadfast in his dedication to advancing outpatient spine surgery. His proprietary Less Exposure Spine Surgery (LESS™) technologies embody not only his pursuit of surgical excellence but also his deep commitment to sharing knowledge, fostering collaboration, and improving patient outcomes. Dr. Chin's work continues to redefine the landscape of less invasive outpatient spine surgery, driven by a relentless mission to advance spine technologies and make a lasting impact on the field, improving the lives of countless patients worldwide.
Dr. Kingsley R Chin (left) and Dr. Anthony T Yeung the pioneering inventor of the Yeung endoscopic spine surgery (YESS) system
Diverse Experience and Business Acumen
Transitioning to the corporate world, Dr. Chin honed his business skills at prestigious institutions like AT&T Bell Labs as an intern and as an experienced management consultant at Accenture New York City, where he provided management information systems consulting for Goldman Sachs and Cigna Insurance. This early experience gave him a unique blend of engineering expertise and business acumen, setting the stage for his groundbreaking entrepreneurial leadership in healthtech after becoming a spine surgeon.
A Remarkable Beginning to his Journey
Dr. Chin’s journey from a small town in Jamaica to becoming a CEO at the forefront of spine surgery technology is truly inspirational. Raised in Buff Bay by a single mother, he learned the values of resilience and determination early on. His journey took a significant turn with a scholarship to Columbia University, where he excelled both academically and athletically, earning recognition as an engineering standout and Ivy League Player of the Year in soccer. He was also elected Student Government president of the Senior Class, further demonstrating his leadership abilities. He credits his success to his ability to overcome adversity and make quick decisions to seize opportunities.
Dr. Kingsley R Chin (left), Dr. Henry Bohlman (middle) and Dr. Augustus White (right)
.jpg)
Dr. Kingsley R Chin and Stryker's Mantis Technology while at NASS
Predicting Technology Growth Markets
Dr. Chin’s ability to identify and lead in emerging healthcare technology sectors has been the driving force behind KIC Ventures’ sustained growth. By anticipating the rise of interventional pain management and ambulatory surgery center (ASC) ownership models, Dr. Chin positioned KIC Ventures to meet the evolving needs of physician-entrepreneurs.
Under his visionary leadership, the firm has achieved double-digit year-over-year revenue growth since 2021, driven by precision investments in LESS Exposure Spine Surgery (LESS) innovation. The strategic acquisitions of AxioMed, with its viscoelastic total disc replacement technology, and NanoFUSE Biologics, featuring patented 45S5 Bioglass®, reflect his commitment to advancing motion preservation and biologic healing.
By uniting surgical innovation, business foresight, and patient-centered outcomes, Dr. Chin continues to redefine traditional spine care—transforming how physicians restore function while preserving anatomy.
History of KIC Ventures' Growth
Founded as a Series LLC in 2005, KIC LLC was built upon the foundation of Dr. Kingsley R. Chin’s pioneering spine patents—forming the cornerstone of a portfolio of companies designed to revolutionize spine care through LESS Exposure Spine Surgery (LESS) innovation.
In 2006, Dr. Chin invested $100,000 of his own capital to launch SpineFrontier Inc., a company dedicated to advancing surgeon-designed, patient-focused spine technologies. This entrepreneurial step came on the heels of the 2005 acquisition of MANTIS LLC by Stryker, a Fortune 500 company—a deal that validated the market potential of Dr. Chin’s early inventions and cemented his reputation as a visionary spine innovator.
By 2013, Dr. Chin formally established KIC Ventures as the venture arm of KIC, accelerating the innovation, commercialization, and scaling of transformative spine technologies. Through disciplined leadership and strategic foresight, he has personally invested tens of millions of dollars, complemented by significant external funding, to drive sustainable, mission-aligned growth.
Today, KIC Ventures stands as a global leader in private equity healthtech, with estimated assets under management in the low billions and a portfolio representing the world’s largest collection of majority-owned spine companies—each exclusively focused on improving outcomes through LESS Exposure Spine Surgery principles. Dr. Chin’s continued majority ownership reflects his enduring belief that restoring function, preserving anatomy, and empowering surgeons define the future of spine care.
A Prime Opportunity for Investors
As KIC Ventures continues its trajectory of innovation and growth, this moment represents a defining opportunity for investors seeking both purpose and performance. Built on nearly two decades of proven leadership and disciplined execution, KIC Ventures offers a unique value proposition: minimized risk, clear scalability, and long-term vision in a multibillion-dollar spine market poised for transformation.
The anticipated 2026 release of AxioMed’s lumbar viscoelastic total disc replacement to U.S. surgeons marks a significant inflection point—one expected to accelerate expansion and unlock substantial enterprise value.
As a private equity healthtech firm, KIC Ventures invests for the future, not the quarter. Our strategy centers on acquiring and developing technologies that deliver sustainable benefits for spine surgeons and their patients. The 2014 acquisition of AxioMed and 2018 acquisition of NanoFUSE Biologics exemplify this philosophy: long-term value creation rooted in scientific validation, peer-reviewed data, and surgeon collaboration.
Our portfolio company NANISX embodies this success—demonstrating consistent profitability and positive EBITDA since 2021 through disciplined commercialization, adoption, and innovation. This performance underscores the strength of our integrated model and the scalability of our LESS Exposure Spine Surgery (LESS) platform.
By allocating a portion of your SDIRA to this Series A round, you’re not merely investing in a company—you’re participating in a mission. Leveraging your SDIRA provides a tax-deferred pathway to growth, aligning your retirement portfolio with a high-impact opportunity driven by innovation, surgeon leadership, and patient-focused outcomes.
The Series A investment round represents a chance to join a proven team at a pivotal moment—anchored by a foundation of innovation, profitability, and vision—positioning KIC Ventures to redefine the future of spine care and deliver enduring value to all stakeholders.
Why Investors Trust Dr. Kingsley R. Chin
Dr. Kingsley R. Chin’s story is one of resilience, discipline, and faith—a journey that began in a small town in Jamaica and led him to the forefront of global spine innovation. His path reflects not only brilliance but endurance: a lifelong pursuit of excellence forged through challenge, conviction, and hard work.
From earning his engineering degree at Columbia University to gaining early business experience at Accenture, Dr. Chin learned the power of combining technical precision with strategic thinking. He went on to earn his medical degree from Harvard, complete his orthopedic surgery residency at Harvard, and pursue a spine surgery fellowship, later becoming Chief of Spine Surgery at the University of Pennsylvania.
Never content to stand still, Dr. Chin returned to Harvard Business School to strengthen his leadership and business acumen—an uncommon path for a practicing surgeon, yet one that reflects his conviction that medicine and entrepreneurship must work hand in hand to drive meaningful change.
His journey has not been without trials. Dr. Chin has faced and overcome significant tests, including a seven-year Department of Justice investigation that ultimately reaffirmed his integrity, and the profound challenges of leading through the COVID-19 era. Each test has refined his perspective, revealing a leader who meets adversity with humility, courage, and unshakable resolve.
Through it all, he has remained deeply grounded in family, balancing the demands of surgery, entrepreneurship, and leadership while raising his children alongside his wife. His core team at KIC Ventures has stood with him for over 17 years, a testament to the loyalty he inspires and the trust he’s earned.
Even as he leads on a global stage, Dr. Chin has never lost sight of his roots in Jamaica. He continues to return home regularly—treating patients, mentoring young physicians, and investing in community development through education and philanthropy. His commitment to giving back reflects the same purpose that drives his professional life: to restore, uplift, and empower others.
Dr. Chin’s life embodies the principles he leads by: faith, perseverance, bold vision, and integrity under pressure. Investors trust him not only because of his record of success, but because he has proven, time and again, that he leads with purpose—and never asks others to believe in anything he hasn’t first risked himself.
Overcoming Dire Challenges
Despite recent challenges, including navigating the Covid-19 pandemic and defending against anti-kickback charges by the Department of Justice dating back to 2013, Dr. Chin’s resilience and commitment to excellence remained unwavering. In 2023, he signed a civil agreement, and in 2025, successfully had all original charges dismissed against him and all his companies. Throughout this period, KIC Ventures’ indispensable leadership remained intact.
Education
-
B.A Mathematics, Columbia University
-
B.S. Electrical, Electronics and Communications Engineering, Columbia University
-
MD Doctor of Medicine (Honors), Harvard Medical School
-
MBA Healthcare Management, Ball State University
-
Degree in Executive Leadership, Harvard Business School
-
Residency in Orthopedic Surgery, Massachusetts General Hospital, Harvard University
-
Orthopedic Reconstructive Surgery Fellowship, Harvard University
-
Henry Bohlman Spine Fellowship, University Hospitals of Cleveland, Case Western Reserve School of Medicine
This book is a potent initiator and energizer. It takes a simplified but holistic approach to success that will motivate and instigate.
From the Foreword
This textbook aims to convey both the art and science of interventional spine care. The editors are all distinguished clinicians and respected researchers.
Preface
"Patients deserve the least aggressive care feasible... when this is accomplished, an algorithmic approach can be offered that adequately balances the potential outcomes and known side effects or complications. "
Curtis W. Slipman
2007
Soundtrack
To our knowledge, this marks the first time a book will be accompanied by a soundtrack... The Prove Yourself Trilogy Album Soundtrack, set to accompany the Prove Yourself book, features three unique albums.
-
Go Get It
-
Fight
-
JamaicHer